| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |